ALPS Advisors’s Vera Therapeutics VERA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.34M Buy
58,087
+5,695
+11% +$245K 0.01% 375
2025
Q4
$2.65M Buy
52,392
+21,642
+70% +$769K 0.02% 348
2025
Q3
$894K Sell
30,750
-3,691
-11% -$85.4K 0.01% 555
2025
Q2
$811K Sell
34,441
-12,071
-26% -$271K ﹤0.01% 564
2025
Q1
$1.12M Sell
46,512
-4,695
-9% -$151K 0.01% 453
2024
Q4
$2.17M Buy
51,207
+6,941
+16% +$307K 0.01% 338
2024
Q3
$1.96M Buy
44,266
+1,432
+3% +$54.3K 0.01% 363
2024
Q2
$1.55M Buy
42,834
+4,102
+11% +$163K 0.01% 376
2024
Q1
$1.67M Buy
38,732
+8,512
+28% +$303K 0.01% 381
2023
Q4
$465K Sell
30,220
-2,490
-8% -$31.6K ﹤0.01% 617
2023
Q3
$448K Buy
32,710
+175
+0.5% +$3K ﹤0.01% 611
2023
Q2
$522K Buy
32,535
+4,906
+18% +$44.3K ﹤0.01% 608
2023
Q1
$214K Buy
27,629
+8,880
+47% +$68.5K ﹤0.01% 979
2022
Q4
$363K Buy
18,749
+4,005
+27% +$72.5K ﹤0.01% 720
2022
Q3
$314K Sell
14,744
-1,316
-8% -$24.6K ﹤0.01% 708
2022
Q2
$219K Buy
+16,060
New +$280K ﹤0.01% 980

Other funds holding VERA